New Method for Analyzing Asymmetric Dimethylarginine Levels
Elevated plasma levels of ADMA are described for a number of diseases as hypertension, hypercholesterolemia, renal insufficiency or diabetes mellitus. The invention provides a method for the simultaneous determination of the concentration of asymmetric dimethylarginine (ADMA), arginine and symmetric dimethylarginine (SDMA) in biological probes using chromatography combined with tandem mass spectrometry.
Further Information: PDF
ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20
Contact
Dr. Stefan Schünemann
